BioNTech Secures $110 Million for Rwanda Vaccine Plant
Kigali, 15 October 2025 — German biotechnology company BioNTech SE has obtained a $110 million financing package from the European Investment Bank (EIB) and the European Commission to support the expansion of its mRNA vaccine plant in Rwanda. The Kigali facility, first inaugurated in 2023 with modular “BioNTainer” units, is designed to strengthen Africa’s vaccine […]
Continue Reading